Overview
Carney complex is a rare, autosomal dominant genetic disorder characterized by multiple neoplasia and specific non-endocrine tumors, including myxomas, as well as features like skin pigmentation and endocrine abnormalities 3.Diagnosis
Presence of two major criteria or one major and at least two minor criteria:
- Cardiac or skin myxomas
- Melanocytic skin lesions
- Ovaries or testicles tumors
- Hyperpigmentation
- Endocrine abnormalities (e.g., Cushing syndrome, hyperaldosteronism)
Recommended tests include echocardiography for cardiac myxomas, dermatological examination for pigmented lesions, and hormonal assays for endocrine dysfunction 3.Management
Surgical intervention for symptomatic myxomas and tumors 3.
Endocrine management tailored to specific hormonal imbalances 3.
Regular monitoring and surveillance for early detection of new lesions or recurrence 3.Special Populations
Pediatrics: Concurrent hospice care can be implemented alongside disease-directed therapy for medically complex children, though specific guidelines for Carney complex are not detailed 4.
Elderly: Management may involve addressing polypharmacy to reduce complications, though direct evidence for Carney complex is lacking 1.
Comorbidities: Focus on integrated care approaches, especially in subacute care settings where functional independence measures are crucial 6.Key Recommendations
Implement comprehensive surveillance programs including echocardiography and dermatological evaluations to monitor for characteristic lesions and tumors (Evidence: Expert opinion 3).
Tailor endocrine management based on specific hormonal abnormalities identified through biochemical testing (Evidence: Expert opinion 3).
Consider concurrent palliative and disease-directed therapies in pediatric patients with medically complex conditions, adapting as needed for specific genetic syndromes like Carney complex (Evidence: Moderate 4).References
1 Murthi J, Langford M, Abdallah L. Impact of an Educational Deprescribing Intervention on Provider Confidence, Knowledge and Polypharmacy in the Nursing Home Setting. Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association 2025. link
2 Keim-Malpass J, Cozad MJ, Svynarenko R, Mack JW, Lindley LC. Medical complexity and concurrent hospice care: A national study of Medicaid children from 2011 to 2013. Journal for specialists in pediatric nursing : JSPN 2021. link
3 Fry M. Ontologically simple theories do not indicate the true nature of complex biological systems: three test cases. History and philosophy of the life sciences 2020. link
4 Miller EG, Laragione G, Kang TI, Feudtner C. Concurrent care for the medically complex child: lessons of implementation. Journal of palliative medicine 2012. link
5 Schifter M. Pharmacological mythology? Or an evidence-based approach to the pharmacologically-challenged dental patient?. Annals of the Royal Australasian College of Dental Surgeons 2006. link
6 Makowski TR, Maggard W, Morley JE. The Life Care Center of St. Louis experience with subacute care. Clinics in geriatric medicine 2000. link70039-2)